• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

果胶裂解酶修饰的人参提取物和人参皂苷 Rd 抑制高糖诱导的系膜细胞 ROS 产生,并预防 db/db 小鼠的肾功能障碍。

Pectin-Lyase-Modified Ginseng Extract and Ginsenoside Rd Inhibits High Glucose-Induced ROS Production in Mesangial Cells and Prevents Renal Dysfunction in db/db Mice.

机构信息

Laboratory of Toxicology, Research Institute for Veterinary Science and College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea.

International Ginseng and Herb Research Institute, 25 Insamgwangjang-ro, Geumsan-eup, Geumsan-gun 32724, Chungcheongnam-do, Korea.

出版信息

Molecules. 2021 Jan 12;26(2):367. doi: 10.3390/molecules26020367.

DOI:10.3390/molecules26020367
PMID:33445772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7828230/
Abstract

Diabetes increases the incidence rate of chronic renal disease. Pectin-lyase-modified ginseng (GS-E3D), with enhanced ginsenoside Rd content, has been newly developed. In this study, renal protective roles of GS-E3D in type-2 diabetic db/db mice were investigated. The generation of reactive oxygen species (ROS) induced by high glucose (25 mM) was reduced by ES-E3D (75%) and ginsenoside Rd (60%). Diabetic db/db mice received 100 or 250 mg/kg/day of GS-E3D daily via oral gavage for 6 weeks. Albuminuria and urinary 8-hydroxy-2'-deoxyguanosine (8-OhdG, an oxidative stress marker) levels were increased in db/db mice and the levels recovered after GS-E3D treatment. In renal tissues, TUNEL-positive cells were decreased after GS-E3D treatment, and the increased apoptosis-related protein expressions were restored after GS-E3D treatment. Therefore, GS-E3D has a potent protective role in diabetes-induced renal dysfunction through antioxidative and antiapoptotic activities. These results may help patients to select a dietary supplement for diabetes when experiencing renal dysfunction.

摘要

糖尿病增加了慢性肾病的发病率。新开发了一种经果胶酶修饰的人参(GS-E3D),其人参皂苷 Rd 含量增加。本研究探讨了 GS-E3D 在 2 型糖尿病 db/db 小鼠中的肾脏保护作用。GS-E3D(75%)和人参皂苷 Rd(60%)可降低高葡萄糖(25 mM)诱导的活性氧(ROS)的产生。糖尿病 db/db 小鼠经口灌胃给予 100 或 250 mg/kg/天的 GS-E3D ,持续 6 周。白蛋白尿和尿 8-羟基-2'-脱氧鸟苷(8-OhdG,氧化应激标志物)水平在 db/db 小鼠中升高,经 GS-E3D 治疗后恢复。在肾脏组织中,TUNEL 阳性细胞在 GS-E3D 治疗后减少,并且 GS-E3D 治疗后恢复了增加的凋亡相关蛋白表达。因此,GS-E3D 通过抗氧化和抗凋亡作用在糖尿病引起的肾功能障碍中具有强大的保护作用。这些结果可能有助于患者在出现肾功能障碍时选择糖尿病的膳食补充剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/93c60d6086dc/molecules-26-00367-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/ff520ea8ea05/molecules-26-00367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/c67a21e71080/molecules-26-00367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/6b1cb843082f/molecules-26-00367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/d085ce0adeed/molecules-26-00367-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/93c60d6086dc/molecules-26-00367-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/ff520ea8ea05/molecules-26-00367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/c67a21e71080/molecules-26-00367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/6b1cb843082f/molecules-26-00367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/d085ce0adeed/molecules-26-00367-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/7828230/93c60d6086dc/molecules-26-00367-g005.jpg

相似文献

1
Pectin-Lyase-Modified Ginseng Extract and Ginsenoside Rd Inhibits High Glucose-Induced ROS Production in Mesangial Cells and Prevents Renal Dysfunction in db/db Mice.果胶裂解酶修饰的人参提取物和人参皂苷 Rd 抑制高糖诱导的系膜细胞 ROS 产生,并预防 db/db 小鼠的肾功能障碍。
Molecules. 2021 Jan 12;26(2):367. doi: 10.3390/molecules26020367.
2
GS-E3D, a new pectin lyase-modified red ginseng extract, inhibited diabetes-related renal dysfunction in streptozotocin-induced diabetic rats.GS-E3D是一种新型果胶裂解酶修饰的红参提取物,可抑制链脲佐菌素诱导的糖尿病大鼠的糖尿病相关肾功能障碍。
BMC Complement Altern Med. 2017 Aug 29;17(1):430. doi: 10.1186/s12906-017-1925-7.
3
Acute and genetic toxicity of GS-E3D, a new pectin lyase-modified red ginseng extract.GS-E3D,一种新型果胶裂解酶修饰红参提取物的急毒和遗传毒性。
Regul Toxicol Pharmacol. 2019 Jun;104:157-162. doi: 10.1016/j.yrtph.2019.03.010. Epub 2019 Mar 21.
4
Ginseng Extract Modified by Pectin Lyase Inhibits Retinal Vascular Injury and Blood-Retinal Barrier Breakage in a Rat Model of Diabetes.果胶裂解酶修饰的人参提取物可抑制糖尿病大鼠模型中的视网膜血管损伤和血视网膜屏障破坏
J Med Food. 2019 Apr;22(4):337-343. doi: 10.1089/jmf.2018.4256. Epub 2019 Feb 20.
5
Pectin lyase-modified red ginseng extract improves glucose homeostasis in high fat diet-fed mice.果胶裂解酶修饰红参提取物改善高脂饮食喂养小鼠的葡萄糖稳态。
J Ethnopharmacol. 2020 Mar 1;249:112384. doi: 10.1016/j.jep.2019.112384. Epub 2019 Nov 13.
6
Ginseng Extracts, GS-KG9 and GS-E3D, Prevent Blood-Brain Barrier Disruption and Thereby Inhibit Apoptotic Cell Death of Hippocampal Neurons in Streptozotocin-Induced Diabetic Rats.人参提取物 GS-KG9 和 GS-E3D 可防止血脑屏障破坏,并抑制链脲佐菌素诱导的糖尿病大鼠海马神经元的凋亡性细胞死亡。
Nutrients. 2020 Aug 9;12(8):2383. doi: 10.3390/nu12082383.
7
Pectin lyase-modified red ginseng extract exhibits potent anti-glycation effects in vitro and in vivo.果胶裂解酶修饰的红参提取物在体外和体内均表现出强大的抗糖基化作用。
J Exerc Nutrition Biochem. 2017 Jun 30;21(2):56-62. doi: 10.20463/jenb.2017.0011.
8
Effects of pectin lyase-modified red ginseng extracts in high-fat diet-fed obese mice.果胶裂解酶修饰的红参提取物对高脂饮食喂养的肥胖小鼠的影响。
Lab Anim Res. 2014 Dec;30(4):151-60. doi: 10.5625/lar.2014.30.4.151. Epub 2014 Dec 24.
9
Renoprotective antioxidant effect of alagebrium in experimental diabetes.藻蓝蛋白在实验性糖尿病中的肾脏保护抗氧化作用。
Nephrol Dial Transplant. 2011 Nov;26(11):3474-84. doi: 10.1093/ndt/gfr152. Epub 2011 Apr 8.
10
Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.穿心莲内酯通过Akt/NF-κB途径减轻高血糖介导的肾脏氧化应激和炎症,从而改善糖尿病肾病。
Mol Cell Endocrinol. 2016 Dec 5;437:268-279. doi: 10.1016/j.mce.2016.06.029. Epub 2016 Jul 1.

引用本文的文献

1
Biomarker-Driven Optimization of Saponin Therapy in MASLD: From Mouse Models to Human Liver Organoids.基于生物标志物的非酒精性脂肪性肝炎中皂苷治疗优化:从小鼠模型到人类肝脏类器官
Antioxidants (Basel). 2025 Jul 31;14(8):943. doi: 10.3390/antiox14080943.
2
Ginsenoside in the treatment of type 2 diabetes and its complications: a promising traditional chinese medicine.人参皂苷在2型糖尿病及其并发症治疗中的应用:一种有前景的传统中药。
Front Pharmacol. 2025 May 13;16:1593780. doi: 10.3389/fphar.2025.1593780. eCollection 2025.
3
Ginseng extract improves pancreatic islet injury and promotes β-cell regeneration in T2DM mice.

本文引用的文献

1
Ginseng Extracts, GS-KG9 and GS-E3D, Prevent Blood-Brain Barrier Disruption and Thereby Inhibit Apoptotic Cell Death of Hippocampal Neurons in Streptozotocin-Induced Diabetic Rats.人参提取物 GS-KG9 和 GS-E3D 可防止血脑屏障破坏,并抑制链脲佐菌素诱导的糖尿病大鼠海马神经元的凋亡性细胞死亡。
Nutrients. 2020 Aug 9;12(8):2383. doi: 10.3390/nu12082383.
2
Pectin lyase-modified red ginseng extract improves glucose homeostasis in high fat diet-fed mice.果胶裂解酶修饰红参提取物改善高脂饮食喂养小鼠的葡萄糖稳态。
J Ethnopharmacol. 2020 Mar 1;249:112384. doi: 10.1016/j.jep.2019.112384. Epub 2019 Nov 13.
3
Acute and genetic toxicity of GS-E3D, a new pectin lyase-modified red ginseng extract.
人参提取物可改善2型糖尿病小鼠的胰岛损伤并促进β细胞再生。
Front Pharmacol. 2024 Jun 25;15:1407200. doi: 10.3389/fphar.2024.1407200. eCollection 2024.
4
Biotransformation, Pharmacokinetics, and Pharmacological Activities of Ginsenoside Rd Against Multiple Diseases.人参皂苷Rd对多种疾病的生物转化、药代动力学及药理活性
Front Pharmacol. 2022 Jul 19;13:909363. doi: 10.3389/fphar.2022.909363. eCollection 2022.
5
Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd.人参皂苷 Rd 的生物转化及药理活性的最新研究进展
Biomolecules. 2022 Mar 28;12(4):512. doi: 10.3390/biom12040512.
GS-E3D,一种新型果胶裂解酶修饰红参提取物的急毒和遗传毒性。
Regul Toxicol Pharmacol. 2019 Jun;104:157-162. doi: 10.1016/j.yrtph.2019.03.010. Epub 2019 Mar 21.
4
Ginseng Extract Modified by Pectin Lyase Inhibits Retinal Vascular Injury and Blood-Retinal Barrier Breakage in a Rat Model of Diabetes.果胶裂解酶修饰的人参提取物可抑制糖尿病大鼠模型中的视网膜血管损伤和血视网膜屏障破坏
J Med Food. 2019 Apr;22(4):337-343. doi: 10.1089/jmf.2018.4256. Epub 2019 Feb 20.
5
Protects Cardio-, Hepato-, and Reno-Antioxidant Status in Streptozotocin-Intoxicated Wistar Rats.保护链脲佐菌素中毒 Wistar 大鼠的心、肝、肾抗氧化状态。
Biomed Res Int. 2018 Nov 25;2018:4907648. doi: 10.1155/2018/4907648. eCollection 2018.
6
Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats.野葛块根水提物对链脲佐菌素诱导的糖尿病肾病大鼠的抗氧化和抗凋亡作用。
BMC Complement Altern Med. 2018 May 11;18(1):156. doi: 10.1186/s12906-018-2221-x.
7
Acute Kidney Injury and Progression of Diabetic Kidney Disease.急性肾损伤与糖尿病肾病进展。
Adv Chronic Kidney Dis. 2018 Mar;25(2):166-180. doi: 10.1053/j.ackd.2017.12.005.
8
Clinico-pathological features of kidney disease in diabetic cases.糖尿病患者肾脏疾病的临床病理特征。
Clin Exp Nephrol. 2018 Oct;22(5):1046-1051. doi: 10.1007/s10157-018-1556-4. Epub 2018 Mar 21.
9
GS-E3D, a new pectin lyase-modified red ginseng extract, inhibited diabetes-related renal dysfunction in streptozotocin-induced diabetic rats.GS-E3D是一种新型果胶裂解酶修饰的红参提取物,可抑制链脲佐菌素诱导的糖尿病大鼠的糖尿病相关肾功能障碍。
BMC Complement Altern Med. 2017 Aug 29;17(1):430. doi: 10.1186/s12906-017-1925-7.
10
Pectin lyase-modified red ginseng extract exhibits potent anti-glycation effects in vitro and in vivo.果胶裂解酶修饰的红参提取物在体外和体内均表现出强大的抗糖基化作用。
J Exerc Nutrition Biochem. 2017 Jun 30;21(2):56-62. doi: 10.20463/jenb.2017.0011.